Physician profile
Edith Saville
NPI 1730567678
$25,986.83
in general payments reported to CMS, 2019-2025
10 companies · $9,463 in 2025
The $9,463 reported for 2025 was more than what 99% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,298 · 2022: $2,036 · 2023: $903 · 2024: $9,286 · 2025: $9,463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $3,972 · Travel and Lodging: $3,685.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,995.00 |
| Food and Beverage | $3,971.90 |
| Travel and Lodging | $3,685.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $19,042.08 | 2021-2025 | Descovy, Yeztugo, Biktarvy |
| Janssen Products, LP | $4,144.99 | 2021-2022 | |
| Viiv Healthcare Company | $1,928.26 | 2021-2025 | Cabenuva, Dovato, Apretude |
| Janssen Biotech, INC. | $509.73 | 2021-2022 | |
| Madrigal Pharmaceuticals | $126.19 | 2025 | Rezdiffra |
| Novo Nordisk INC | $124.97 | 2025 | Wegovy |
| Abbvie INC. | $36.54 | 2025 | |
| Janssen Pharmaceuticals, INC | $28.48 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $25.59 | 2023 | Xifaxan |
| Theratechnologies INC. | $20.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edith Saville listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.